An Exploratory Study of the Effects of Trelagliptin and Alogliptin on Glucose Variability in Patients With Type 2 Diabetes Mellitus
Clinical trial NCT02771093 · COMPLETED
Trial details
- NCT number
- NCT02771093
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-08
- Primary completion
- 2017-04-27
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.